Pandemic Preparedness and Response
Pandemic Preparedness and Response


Our Approach to Pandemic Preparedness and Health Security
Pandemics expose the strength—or fragility—of health systems. Management Sciences for Health (MSH) works with governments and partners to build resilient systems that detect, prevent, and respond to disease threats while continuing to deliver essential health services.
Our approach integrates pandemic preparedness into the everyday functioning of health systems—from community surveillance and laboratory networks to supply chains, governance, and health workforce capacity—so countries can act quickly when threats emerge.
Pandemic preparedness and health security
Pandemics test the strength of health systems. When surveillance systems fail to detect outbreaks early, when supply chains break down, or when health workers lack the tools to respond, health emergencies can escalate quickly and disrupt essential care.
At MSH, pandemic preparedness is not a standalone activity. It is the result of strong, well-functioning health systems that can detect threats early, respond effectively, and continue delivering essential services.
We work with governments and partners to strengthen the institutions and systems that make health security possible—ensuring countries are equipped not only to respond to emergencies, but to prevent and contain them.
Our Approach
MSH supports countries to build sustainable preparedness through investments in the core capabilities that underpin health security:
- Leadership and governance: Supporting national and subnational leadership to coordinate preparedness planning, emergency response, and cross-sector collaboration.
- Surveillance and early detection: Strengthening disease surveillance systems, laboratory networks, and data use so countries can detect and respond to outbreaks quickly.
- Resilient pharmaceutical and supply systems: Ensuring medicines, vaccines, diagnostics, and essential supplies remain available during health emergencies.
- Health workforce readiness: Building the capacity of health workers and managers to prevent infection, manage outbreaks, and sustain service delivery during crises.
- Community engagement and trust: Working with communities to strengthen risk communication, build trust, and support early response.
- Continuity of essential services: Helping health systems maintain primary health care and other critical services even during major disruptions.
Health Security Through Strong Systems
Experience from COVID-19 reinforced a critical lesson: preparedness cannot be built during a crisis. It must be embedded in the everyday functioning of health systems.
Across Africa, Asia, and other regions, MSH works with governments to integrate preparedness into broader health system strengthening—linking surveillance, supply chains, workforce development, and primary health care.
By strengthening these foundations, countries are better equipped to prevent outbreaks, respond effectively when threats emerge, and protect the health of their populations.
A Culture of Readiness and Local Agency: MSH’s Position on Pandemic Preparedness and Response
The Road to a Chikungunya Vaccine: Accelerating Solutions to Addressing Health Threats Posed by Climate Change
Chikungunya, a mosquito-borne viral disease, is a growing global threat. As climate change continues to intensify the effects of vector-borne diseases like chikungunya, the global community will need a comprehensive understanding of the disease burden and intervention landscape to inform how to most effectively accelerate response efforts.
From Rowing to Steering: An Old Challenge in a New Environment
Our Response to COVID-19
Since COVID-19 emerged in early 2020, MSH—working through a range of global, regional, and bilateral projects—has supported 27 countries in effectively maintaining essential health services and confronting immediate pandemic challenges and underlying systemic weaknesses drawing on our experience supporting country responses to HIV, tuberculosis, Ebola, avian flu, pneumonic plague, cholera epidemics, and other public health emergencies since 1971. Between 2021 and 2022, our teams supported the COVID-19 vaccine introduction in 17 countries.







